Patents by Inventor Nathaniel L. Wilganowski

Nathaniel L. Wilganowski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11191778
    Abstract: In some aspects, the present disclosure provides compositions comprising an N4-based MMC ligand, a cell targeting group, and a fluorophore or a therapeutic compound comprising a formula: wherein the variables are as defined herein. In some embodiments, these compositions may be used in the imaging techniques or in the treatment of a disease or disorder such as cancer.
    Type: Grant
    Filed: July 26, 2019
    Date of Patent: December 7, 2021
    Assignee: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Ali Azhdarinia, Sukhen C. Ghosh, Nathaniel L. Wilganowski, Eva M. Sevick-Muraca
  • Publication number: 20200085862
    Abstract: In some aspects, the present disclosure provides compositions comprising an N4-based MMC ligand, a cell targeting group, and a fluorophore or a therapeutic compound comprising a formula: wherein the variables are as defined herein. In some embodiments, these compositions may be used in the imaging techniques or in the treatment of a disease or disorder such as cancer.
    Type: Application
    Filed: July 26, 2019
    Publication date: March 19, 2020
    Inventors: Ali AZHDARINIA, Sukhen C. GHOSH, Nathaniel L. WILGANOWSKI, Eva M. SEVICK-MURACA
  • Patent number: 10441607
    Abstract: In some aspects, the present disclosure provides compositions comprising an N4-based MMC ligand, a cell targeting group, and a fluorophore or a therapeutic compound comprising a formula: wherein the variables are as defined herein. In some embodiments, these compositions may be used in the imaging techniques or in the treatment of a disease or disorder such as cancer.
    Type: Grant
    Filed: February 22, 2017
    Date of Patent: October 15, 2019
    Assignee: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Ali Azhdarinia, Sukhen C. Ghosh, Nathaniel L. Wilganowski, Eva M. Sevick-Muraca
  • Publication number: 20080213878
    Abstract: Novel human polynucleotide and polypeptide sequences are disclosed that can be used in therapeutic, diagnostic, and pharmacogenomic applications.
    Type: Application
    Filed: March 1, 2006
    Publication date: September 4, 2008
    Inventors: Gregory Donoho, Carl Johan Friddle, Glenn Friedrich, Brenda Gerhardt, Erin Hilbun, Yi Hu, Brian Mathur, Maricar Miranda, Michael C. Nehls, Boris Nepomnichy, Arthur T. Sands, John Scoville, Hong Sun, C. Alexander Turner, D. Wade Walke, Xiaoming Wang, Nathaniel L. Wilganowski, Xuanchuan Yu, Brian Zambrowicz
  • Patent number: 7374933
    Abstract: Novel human polynucleotide and polypeptide sequences are disclosed that can be used in thereapeutic, diagnostic, and pharmacogenomic applications.
    Type: Grant
    Filed: April 12, 2001
    Date of Patent: May 20, 2008
    Assignee: Lexicon Pharmaceuticals, Inc.
    Inventors: D. Wade Walke, Nathaniel L. Wilganowski, C. Alexander Turner, Jr.
  • Publication number: 20080102520
    Abstract: Novel human polynucleotide and polypeptide sequences are disclosed that can be used in therapeutic, diagnostic, and pharmacogenomic applications.
    Type: Application
    Filed: February 17, 2006
    Publication date: May 1, 2008
    Inventors: Alejandro Abuin, Michael B. Burnett, Emily B. Cullinan, Gregory Donoho, Dorit B. Donoviel, Carl Johan Friddle, Glenn Friedrich, Brenda Gerhardt, Erin Hilbun, Yi Hu, Brian Mathur, Maricar Miranda, Michael C. Nehls, Boris Nepomnichy, David George Potter, David Reed Powell, Arthur T. Sands, John Scoville, Hong Sun, C. Alexander Turner, D. Wade Walke, Frank Wattler, Nathaniel L. Wilganowski, Xuanchuan Yu, Brian Zambrowicz
  • Publication number: 20080050809
    Abstract: Novel human polynucleotide and polypeptide sequences are disclosed that can be used in therapeutic, diagnostic, and pharmacogenomic applications.
    Type: Application
    Filed: June 23, 2005
    Publication date: February 28, 2008
    Inventors: Alejandro Abuin, Gregory Donoho, Carl Johan Friddle, Glenn Friedrich, Brenda Gerhardt, Erin Hilbun, Yi Hu, James Alvin Kieke, Brian Mathur, Daniel Mathur, Maricar Miranda, Michael C. Nehls, Boris Nepomnichy, Arthur T. Sands, John Scoville, C. Alexander Turner, D. Wade Walke, Xiaoming Wang, Nathaniel L. Wilganowski, Amy Qiongshu Xie, Xuanchuan Yu, Brian Zambrowicz
  • Patent number: 6929937
    Abstract: Novel human polynucleotide and polypeptide sequences are disclosed that can be used in therapeutic, diagnostic, and pharmacogenomic applications.
    Type: Grant
    Filed: February 11, 2003
    Date of Patent: August 16, 2005
    Assignee: Lexicon Genetics Incorporated
    Inventors: C. Alexander Turner, Jr., Glenn Friedrich, Alejandro Abuin, Brian Zambrowicz, Arthur T. Sands, D. Wade Walke, Nathaniel L. Wilganowski
  • Patent number: 6852840
    Abstract: Novel human polynucleotide and polypeptide sequences are disclosed that can be used in therapeutic, diagnostic, and pharmacogenomic applications.
    Type: Grant
    Filed: May 11, 2004
    Date of Patent: February 8, 2005
    Assignee: Lexicon Genetics Incorporated
    Inventors: Xuanchuan Yu, John Scoville, Nathaniel L. Wilganowski, Nghi D. Nguyen
  • Patent number: 6841377
    Abstract: Novel human polynucleotide and polypeptide sequences are disclosed that can be used in therapeutic, diagnostic, and pharmacogenmic applications.
    Type: Grant
    Filed: June 13, 2002
    Date of Patent: January 11, 2005
    Assignee: Lexicon Genetics Incorporated
    Inventors: Yi Hu, Nathaniel L. Wilganowski, Carl Johan Friddle, D. Wade Walke
  • Patent number: 6838275
    Abstract: Novel human polynucleotide and polypeptide sequences are disclosed that can be used in therapeutic, diagnostic, and pharmacogenomic applications.
    Type: Grant
    Filed: August 12, 2002
    Date of Patent: January 4, 2005
    Assignee: Lexicon Genetics Incorporated
    Inventors: D. Wade Walke, Nathaniel L. Wilganowski, C. Alexander Turner, Jr.
  • Patent number: 6815538
    Abstract: Novel human polynucleotide and polypeptide sequences are disclosed that can be used in therapeutic, diagnostic, and pharmacogenomic applications.
    Type: Grant
    Filed: March 20, 2001
    Date of Patent: November 9, 2004
    Assignee: Lexicon Genetics Incorporated
    Inventors: D. Wade Walke, Nathaniel L. Wilganowski, C. Alexander Turner, Jr., Erin Hilbun, Xiaoming Wang, Gregory Donoho, John Scoville
  • Publication number: 20040203110
    Abstract: Novel human polynucleotide and polypeptide sequences are disclosed that can be used in therapeutic, diagnostic, and pharmacogenomic applications.
    Type: Application
    Filed: May 11, 2004
    Publication date: October 14, 2004
    Inventors: Xuanchuan Yu, John Scoville, Nathaniel L. Wilganowski, Nghi D. Nguyen
  • Patent number: 6790660
    Abstract: Novel human polynucleotide and polypeptide sequences are disclosed that can be used in therapeutic, diagnostic, and pharmacogenomic applications.
    Type: Grant
    Filed: September 18, 2002
    Date of Patent: September 14, 2004
    Assignee: Lexicon Genetics Incorporated
    Inventors: Xuanchuan Yu, John Scoville, Nathaniel L. Wilganowski, Nghi D. Nguyen
  • Publication number: 20030220491
    Abstract: Novel human polynucleotide and polypeptide sequences are disclosed that can be used in therapeutic, diagnostic, and pharmacogenomic applications.
    Type: Application
    Filed: January 15, 2003
    Publication date: November 27, 2003
    Inventors: D. Wade Walke, Nathaniel L. Wilganowski, Yi Hu, James Alvin Kieke, Brian Zambrowicz, Jean-Pierre Revelli, C. Alexander Turner
  • Publication number: 20030144497
    Abstract: Novel human polynucleotide and polypeptide sequences are disclosed that can be used in therapeutic, diagnostic, and pharmacogenomic applications.
    Type: Application
    Filed: February 11, 2003
    Publication date: July 31, 2003
    Inventors: Gregory Donoho, Erin Hilbun, C. Alexander Turner, Glenn Friedrich, Alejandro Abuin, Brian Zambrowicz, Arthur T. Sands, D. Wade Walke, Nathaniel L. Wilganowski, Yi Hu, James Alvin Kieke, David George Potter
  • Publication number: 20030139587
    Abstract: Novel human polynucleotide and polypeptide sequences are disclosed that can be used in therapeutic, diagnostic, and pharmacogenomic applications.
    Type: Application
    Filed: December 3, 2002
    Publication date: July 24, 2003
    Inventors: D. Wade Walke, Nathaniel L. Wilganowski, C. Alexander Turner
  • Patent number: 6555669
    Abstract: Novel human polynucleotide and polypeptide sequences are disclosed that can be used in therapeutic, diagnostic, and pharmacogenomic applications.
    Type: Grant
    Filed: February 28, 2001
    Date of Patent: April 29, 2003
    Assignee: Lexicon Genetics Incorporated
    Inventors: Gregory Donoho, Erin Hilbun, C. Alexander Turner, Jr., Glenn Friedrich, Alejandro Abuin, Brian Zambrowicz, Arthur T. Sands, D. Wade Walke, Nathaniel L. Wilganowski, Yi Hu, James Alvin Kieke, David George Potter
  • Publication number: 20030004328
    Abstract: Novel human polynucleotide and polypeptide sequences are disclosed that can be used in therapeutic, diagnostic, and pharmacogenomic applications.
    Type: Application
    Filed: August 12, 2002
    Publication date: January 2, 2003
    Inventors: D. Wade Walke, Nathaniel L. Wilganowski, C. Alexander Turner
  • Publication number: 20020164627
    Abstract: Novel human polynucleotide and polypeptide sequences are disclosed that can be used in therapeutic, diagnostic, and pharmacogenomic applications.
    Type: Application
    Filed: March 6, 2002
    Publication date: November 7, 2002
    Inventors: Nathaniel L. Wilganowski, Boris Nepomnichy, Michael B. Burnett, Yi Hu